Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Current Leases: 2021-2024

Historic Current Leases for Prime Medicine (PRME) over the last 4 years, with Dec 2024 value amounting to $3.6 million.

  • Prime Medicine's Current Leases rose 72.03% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 72.03%. This contributed to the annual value of $3.6 million for FY2024, which is 61.04% down from last year.
  • Per Prime Medicine's latest filing, its Current Leases stood at $3.6 million for FY2024, which was down 61.04% from $9.3 million recorded in FY2023.
  • Prime Medicine's Current Leases' 5-year high stood at $11.7 million during FY2022, with a 5-year trough of $3.6 million in FY2024.
  • Its 3-year average for Current Leases is $8.2 million, with a median of $9.3 million in 2023.
  • In the last 5 years, Prime Medicine's Current Leases soared by 59.41% in 2022 and then slumped by 61.04% in 2024.
  • Over the past 4 years, Prime Medicine's Current Leases (Yearly) stood at $7.3 million in 2021, then soared by 59.41% to $11.7 million in 2022, then dropped by 20.68% to $9.3 million in 2023, then crashed by 61.04% to $3.6 million in 2024.